CHARLESTON, SC--(Marketwire - October 08, 2012) - Revolutions Medical Corporation (“Revolutions Medical” or the “Company”) (OTCQB: RMCP) announced today that it has signed a sales and marketing agreement with MedPro Associates (“MedPro”) to expand U.S. sales of its flagship product, the RevVac™ vacuum auto-retractable safety syringe. MedPro will provide regional field sales representatives across the continental Unites States and will initially focus on sales and distribution within the long-term care segment of the medical industry.
Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical, stated, “I believe that with this agreement in place, MedPro, who represents some of the premier manufacturers in the United States, can provide market penetration of the RevVac™ safety syringe domestically. We are pleased that this distinguished sales and marketing group with decades of experience, sees the value and benefits of our product, and has agreed to make the RevVac™ safety syringe available to their customers.”
“We are extremely excited with the addition of our new partner Revolutions Medical to the MedPro family of manufacturers. Our Long Term Care group of over 30 sales professionals nation-wide will now represent the line of RevVac™ safety syringes to our existing customers and distributors. We expect a successful launch campaign and believe increased incremental market share is possible with this next generation of syringe technology”, said Manny Losada President/CEO of MedPro Associates and The Palm Tree Group.
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its proprietary technologies and products include; the RevVac™ safety syringe, safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS), and prefilled vacuum auto-retraction safety syringes.
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.
About MedPro Associates
MedPro Associates is the largest national contract sales organization specializing in dedicated, managed sales divisions by class of trade. Manufacturer lines represented include: Smith & Nephew - Skin Care & Advanced Wound Care (www.smithnephew.com) Drive Medical - Durable Medical Equipment (www.drivemedical.com) Welch Allyn - Diagnostic Equipment (www.welchallyn.com) Zoll - Defibrillators (AED’s) (www.zoll.com) and Revolutions Medical - Vacuum Auto-Retractable Safety Syringes.
For more information on MedPro Associates go to www.mproassociates.com
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT:
Revolutions Medical Corporation
Investor Relations
843-606-9461
